Literature DB >> 20798025

Cancer survivors' return to work: importance of work accommodations and collaboration between stakeholders.

Marja-Liisa Lindbohm1, Eira Viikari-Juntura.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20798025     DOI： 10.1136/oem.2009.051847

Source DB:  PubMed          Journal:  Occup Environ Med        ISSN： 1351-0711            Impact factor:   4.402


× No keyword cloud information.
  5 in total

Review 1.  Qualitative meta-synthesis of survivors' work experiences and the development of strategies to facilitate return to work.

Authors:  Mary Stergiou-Kita; Alisa Grigorovich; Victrine Tseung; Elizabeth Milosevic; Debbie Hebert; Stephanie Phan; Jennifer Jones
Journal:  J Cancer Surviv       Date:  2014-07-04       Impact factor: 4.442

2.  Worksite adjustments and work ability among employed cancer survivors.

Authors:  Steffen Torp; Roy A Nielsen; Sævar B Gudbergsson; Alv A Dahl
Journal:  Support Care Cancer       Date:  2011-11-16       Impact factor: 3.603

3.  A Sensibility Assessment of the Job Demands and Accommodation Planning Tool (JDAPT): A Tool to Help Workers with an Episodic Disability Plan Workplace Support.

Authors:  Monique A M Gignac; Julie Bowring; Sabrina Tonima; Renee-Louise Franche; Aaron Thompson; Arif Jetha; Peter M Smith; Joy C Macdermid; William S Shaw; Dwayne Van Eerd; Dorcas E Beaton; Emma Irvin; Emile Tompa; Ron Saunders
Journal:  J Occup Rehabil       Date:  2022-07-14

4.  The provision of workplace accommodations following cancer: survivor, provider, and employer perspectives.

Authors:  Mary Stergiou-Kita; Cheryl Pritlove; Dwayne van Eerd; Linn D Holness; Bonnie Kirsh; Andrea Duncan; Jennifer Jones
Journal:  J Cancer Surviv       Date:  2015-10-31       Impact factor: 4.442

5.  Effect of employers' concerns about cancer countermeasures on the implementation of cancer screening and support for balancing cancer treatment and work in small and medium-sized Japanese enterprises.

Authors:  Masanari Minamitani; Masayuki Tatemichi; Tomoya Mukai; Atsuto Katano; Keiichi Nakagawa
Journal:  J Occup Health       Date:  2022-01       Impact factor: 2.570
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.